
IN THE DIAGNOSIS
OF BLOOD INFECTION


THE PROBLEM
2-5 days for targeted antibiotic treatment is not good enough
The challenges facing patients, physicians, and healthcare when sepsis and bloodstream infection are suspected are well documented. Increased risk of mortality, the high burden on healthcare budgets, and antimicrobial resistance all conspire to reduce the life chances of patients with sepsis when the time for effective treatment is a matter of life or death.
The standard of care for diagnosing a patient with suspected bloodstream infection is a system of culture-based methods that rely on the growth of organisms over 1-5 days where only then can the physician target antibiotics effectively.
This culturing step is a barrier to speeding up time-to-result for thousands of existing instruments and the adoption of newer, novel technologies.

AUTOMATED SAMPLE PROCESSOR
Momentum is developing an automated sample processor for random-access preparation of blood samples for SepsiTECT® and SepsiPURE®
The SepsiTECT® output can be analysed using any suitable qPCR instrument. The SepsiPURE® output is analysed using similar workflows to current standards.
OXFORD
Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN
TEL: +44 (0)29 2167 7910
CARDIFF
Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF
TEL: +44 (0)29 2167 7910
OXFORD
Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN
TEL: +44 (0)29 2167 7910
CARDIFF
Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF
TEL: +44 (0)29 2167 7910
OXFORD
Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN
TEL: +44 (0)29 2167 7910
CARDIFF
Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF
TEL: +44 (0)29 2167 7910
© 2022 Momentum Bioscience Ltd. All Rights Reserved.
Website by Hatch